MiFID II Unbundling Relief Period Extended to 2023 by SEC

The US Securities and Exchange Commission has granted a three-year extension to the MiFID II relief period for American firms.

The SEC will allow US brokers to continue bundling execution and research payments for another three years. In October of 2017, the SEC published a ‘no-action letter’, stating that American firms did not need to actively adhere to MiFID II’s unbundling guidelines. This letter was due to expire in July 2020. 

This latest statement by the SEC extends this relief period by three years. This means that, until July 2020, US broker-dealers will not be faced with enforcement action for receiving payments in dollars or through research payment accounts from clients that are subject to MiFID II. 

MiFID II’s unbundling guidelines state that payments for execution and research from third-parties must be separated, or ‘unbundled’. This was implemented in an attempt to protect investors and increase market transparency. While these rules have only been enforced in Europe, a number of Global institutions have chosen to implement the guidelines as well.

When asked to explain his decision, Jay Clayton, Chairman of the American securities watchdog, stated that the SEC needed more time to evaluate the longterm impact of MiFID II’s unbundling guidelines. 

‘The impacts of MiFID II are evolving, as EU authorities and regulators in individual EU member states evaluate its effects and consider whether to modify their rules’, stated Clayton. ‘Today’s extension will allow our staff to continue to monitor the evolving impact of MiFID II and evaluate whether any additional guidance or Commission action is appropriate. In this regard, our staff is focused on ensuring that market participants have flexibility and choice in how they pay for research’. 

Despite Clayton and the SEC’s hesitancy, there is some reason to believe that MiFID II’s unbundling guidelines have been successful. In a report published by the FCA in September 2019, it was claimed that MiFID II’s unbundling rules ‘have improved asset managers’ accountability over costs, saving millions for investors’. 

There is a fair amount of support for the unbundling rules in America as well. According to a survey by TABB Group, only 33% of large US-based buy-side firms were still bundling research and execution payments. They also found that the buy-side in the US are increasingly in favour of implementing the unbundling rules.


FCA Addresses Market Abuse Concerns During COVID-19

FCA Market Watch 63 Addresses Market Conduct During Coronavirus Pandemic  In their latest Market Watch newsletter, the FCA have addressed the importance of proper ‘market conduct and discipline in the context of coronavirus’.  In a direct appeal, Market Watch 63...

Clashes Between EU and UK Asset Managers Over MiFID II Unbundling

Disagreement Over Research Unbundling Between UK and EU Fund Managers As part of the regulatory framework enacted by MiFID II in January of 2018, asset managers were required to separate the cost of research from other costs such as trading commissions. This...

COVID-19 Exposes Gaps in Market Data Supply

Market Data Vendors Struggle to Keep Up Amid Coronavirus Pandemic Since the outbreak of COVID-19 has spread and made its impact known on global markets, a number of banks and investment firms have been required to fall back on Business Continuity Measures (BCP). As a...

Best Execution Reporting During the COVID-19 Pandemic

ESMA Releases Public Statement on MiFID II Best Execution Reporting During COVID-19 Pandemic The disruption to markets caused by preventative lockdowns in response to the Coronavirus pandemic has caused execution venues and firms a great deal of uncertainty with...

ESMA Publishes Opinions on Position Limits under MiFID II

Updated Opinions on Position Limits Under MiFID II Published by ESMA On February 7th, ESMA published seven opinions on position limits regarding commodity derivatives under MiFID II/MiFIR.  The opinions published by ESMA agree with a number of proposed position limits...

Get In Touch